Multiple Manufacturers

ISOVUE-200

Manufacturer:

Multiple Manufacturers

Isovue-200 HCPCS:

Q9966

HCPCS Code Descriptor:

Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml

Category:

Q Code

Isovue-200 NDCs:

00407-2222-21, 65219-0381-50, 00407-1412-35, 00407-2222-19, 00407-1412-34, 65219-0381-10, 00407-2222-17, 00270-1411-25, 50419-0342-21, 00407-1412-33, 00270-1317-41, 70436-0124-52, 00270-1411-11, 00270-1314-15, 00407-2222-16, 70436-0124-82, 00407-1412-20, 00407-1412-10, 00019-1324-06, 00270-1317-02, 00407-1412-30, 00407-1412-38, 50419-0342-10, 00019-1324-11, 00270-1317-05, 00270-1314-30

Primary Type:

Imaging/Radiopharmaceutical

Generic/Specialty Status:

Multi-Source

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00270-1411-25, 50419-0342-21, 00270-1317-41, 00270-1314-15, 00407-2222-16, 00019-1324-06, 00270-1317-02, 50419-0342-10, 00019-1324-11, 00270-1317-05, 00270-1314-30

About Isovue-200:

ISOVUE-200 is an Imaging/Radiopharmaceutical drug manufactured by Bracco Diagnostics and administered via the Injection route of administration. The Q Code: Q9966 is aligned to the drug ISOVUE-200.

Isovue-200, also known as iopamidol, is an injection used to help diagnose disorders of the brain, heart, head, blood vessels, and other body parts. Isovue-200 is what's known as am iodinated contrast agent. It contains iodine, which absorbs x-rays. Isovue-200 can be administered before a patient receives an x-ray or a CT scan to create a clearer picture of what's happening in the body, allowing doctors to make more accurate diagnoses.

ACCESS PRICING AND MORE BY REGISTERING

Q9966 Added Date:

January 1, 2008

Q9966 Effective Date:

January 1, 2008

Q9966 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Isovue-200 billing and coding information.
Our team did not identify a source for Isovue-200 patient assistance information. Please reach out to our team if you feel that this is a mistake.
Our team is still working to identify a prescribing information source for ISOVUE-200
Our team has not yet identified a source of side effects information for ISOVUE-200. Please check back in a few weeks.